Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

National Institute of Environmental Health Sciences

Use this QR code to view the newest version of this document
Use this QR code to view the newest version of this document

Your Environment. Your Health.

Publication Detail

Title: Management of fast breathing pneumonia in young infants aged 7 to 59 days by community level health workers: protocol for a multi-centre cluster randomized controlled trial.

Authors: Enhanced Management of Pneumonia in Community (EMPIC) Study Group; Mothabbir, Golam; Rana, Shohel; Baqui, Abdullah H; Ahmed, Salahuddin; Ahmed, Asm Nawshad; Taneja, Sunita; Mundra, Sudarshan; Bhandari, Nita; Dalpath, Suresh; Tigabu, Zemene; Andargie, Gashaw; Teklu, Alemayehu; Tazebew, Ashenafi; Alemu, Kassahun; Awoke, Tadese; Gebeyehu, Abebaw; Jenda, Gomezgani; Nsona, Humphreys; Mathanga, Don; Nisar, Yasir Bin; Bahl, Rajiv; Sadruddin, Salim; Muhe, Lulu; Moschovis, Peter; Aboubaker, Samira; Qazi, Shamim

Published In Int J Clin Trials, (2020 Apr-Jun)

Abstract: BACKGROUND: WHO does not recommend community-level health workers (CLHWs) using integrated community case management (iCCM) to treat 7-59 days old infants with fast breathing with oral amoxicillin, whereas World Health Organization (WHO) integrated management of childhood illness (IMCI) recommends it. We want to collect evidence to help harmonization of both protocols. METHODS: A cluster, randomized, open-label trial will be conducted in Africa and Asia (Ethiopia, Malawi, Bangladesh and India) using a common protocol with the same study design, inclusion criteria, intervention, comparison, and outcomes to contribute to the overall sample size. This trial will also identify hypoxaemia in young infants with fast breathing. CLHWs will assess infants for fast breathing, which will be confirmed by a study supervisor. Enrolled infants in the intervention clusters will be treated with oral amoxicillin, whereas in the control clusters they will be managed as per existing iCCM protocol. An independent outcome assessor will assess all enrolled infants on days 6 and 14 of enrolment for the study outcomes in both intervention and control clusters. Primary outcome will be clinical treatment failure by day 6. This trial will obtain approval from the WHO and site institutional ethics committees. CONCLUSIONS: If the research shows that CLHWs can effectively and safely treat fast breathing pneumonia in 7-59 days old young infants, it will increase access to pneumonia treatment substantially for infants living in communities with poor access to health facilities. Additionally, this evidence will contribute towards the review of the current iCCM protocol and its harmonization with IMCI protocol. TRIAL REGISTRATION: The trial is registered at AZNCTR International Trial Registry as ACTRN12617000857303.

PubMed ID: 33163583 Exiting the NIEHS site

MeSH Terms: No MeSH terms associated with this publication

Back
to Top